OBIO
Orchestra BioMed Holdings, Inc.
$3.92
-0.04 (-1.01%)
At close · Jul 8
Market Cap
$233.83M
Shares
59,880,715
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.92
Open$3.92
Day$3.80–3.95
52W$2.20–5.42
Avg vol 30d396K
Short int1.2M · 2.1% float · 5.6d
Short vol81%
DataAug 2020–Jul 2026
Filing10-Q · May 12
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
Death cross
Price vs 200-day avg
−3%
below
Price vs 50-day avg
−2%
below
RSI (14)
45
neutral
MACD trend
Negative
52-week position
53%
mid-range
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−8%
trailing
YTD return
−6%
this year
Relative strength
−16%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Death cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+3% holders QoQ · +19 funds added
Insider flow
Accumulating
Net +$99.9K over 90 days · 40% sells
Short interest
Rising
2.07% of float · ▲ +30.6% MoM · 5.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
65 holders — near 3-yr high, broad support
Squeeze score
68
elevated · 0–100
Fundamentals
Revenue growth
+1169%
Y/Y
EPS growth
+33%
Y/Y
Free cash flow
$-49.5M
Balance sheet
$19.7M
net cash
Quant / Vol
risk profile
Volatility
72%
annualized · 1-yr
Max drawdown
−35%
past year
ATR
6.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
Death cross
Bearish
Price vs 200-day avg
−3%
Neutral
Price vs 50-day avg
−2%
Neutral
RSI (14)
45
Neutral
MACD trend
Negative
Bearish
52-week position
53%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
Death cross
50d $4 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+3% holders QoQ · +19 funds added
Insider flow
Accumulating
Net +$99.9K over 90 days · 40% sells
Short interest
Rising
2.07% of float · ▲ +30.6% MoM · 5.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
65 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $4 · 53%
52-wk high $5
vs 200-day avg -3%
vs 50-day avg -2%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OBIO
this stock
Orchestra BioMed Holdings, Inc.
|
$233.83M | -5.5% | +1169.2% | — | 2.1% |
|
ONC
BeOne Medicines Ltd.
|
$436.30B | -0.6% | +22179.2% | 887.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OBIO | -9.2% | -0.8% | -8.4% | -9.2% | -5.5% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -9.0% | -1.6% | -15.9% | -9.0% | -14.9% |